These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 815533)

  • 21. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antigens of the subcellular fractions of Trypanosoma cruzi. I. Localization of antigens and proteins in the subcellular fractions].
    Segura EL; Campos JM; de Ducatenzeiler AB; Cerisola JA
    Medicina (B Aires); 1975; 35(5):451-9. PubMed ID: 55942
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental Chagas' disease in mice infected with one LD50 of parasite.
    Repka D; Rangel HA; Atta AM; Gavino VA; Piedrabuena AE
    Rev Bras Biol; 1985 Aug; 45(3):309-16. PubMed ID: 3938552
    [No Abstract]   [Full Text] [Related]  

  • 24. BCG-induced resistance in Trypanosoma cruzi experimental infections.
    Bertelli MS; Alcantara A; Brener Z
    Tropenmed Parasitol; 1981 Jun; 32(2):93-6. PubMed ID: 6789512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytotoxic activity of the leukocytes of chronic Chagas' disease patients against Trypanosoma cruzi].
    Olabuenaga SE; Rimoldi MT; Cardoni RL; Riera NE; Sánchez RA; Chiale P; de Bracco MM
    Medicina (B Aires); 1983; 43(2):168-74. PubMed ID: 6420643
    [No Abstract]   [Full Text] [Related]  

  • 26. Trypanosoma cruzi infection beats the B-cell compartment favouring parasite establishment: can we strike first?
    Acosta Rodriguez EV; Zuniga EI; Montes CL; Merino MC; Bermejo DA; Amezcua Vesely MC; Motran CC; Gruppi A
    Scand J Immunol; 2007; 66(2-3):137-42. PubMed ID: 17635791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytophilic antibody in experimental Chagas' disease.
    Kuhn RE; Cassida GW
    J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular immunity in Chagas' disease patients. Lymphoproliferative response to subcellular fractions of Trypanosoma cruzi.
    De Titto EH; Segura EL; Braun M
    Immunol Lett; 1983 Mar; 6(3):161-7. PubMed ID: 6407983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione.
    Ouaissi A; Guevara-Espinoza A; Chabé F; Gomez-Corvera R; Taibi A
    Immunol Lett; 1995 Dec; 48(3):221-4. PubMed ID: 8867855
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide.
    Pinge-Filho P; Peron JP; de Moura TR; Menolli RA; Graça VK; Estevão D; Tadokoro CE; Jankevicius JV; Rizzo LV
    Immunol Lett; 2005 Jan; 96(2):283-90. PubMed ID: 15585334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chagas' disease: potential for immunoprophylaxis.
    Lancet; 1980 Mar; 1(8166):466. PubMed ID: 6102192
    [No Abstract]   [Full Text] [Related]  

  • 33. Protective immunisation of mice using cell surface glycoprotein from Trypanosoma cruzi.
    Scott MT; Snary D
    Nature; 1979 Nov; 282(5734):73-4. PubMed ID: 116128
    [No Abstract]   [Full Text] [Related]  

  • 34. Antigenic makeup of subcellular fractions of Trypanosoma cruzi.
    Segura EL; Cura EN; Paulone I; Vasquez C; Cerisola JA
    J Protozool; 1974 Oct; 21(4):571-4. PubMed ID: 4371015
    [No Abstract]   [Full Text] [Related]  

  • 35. Experiments on immunoprophylaxis against Chagas' disease.
    Hanson WL
    Adv Exp Med Biol; 1977; 93():281-3. PubMed ID: 413342
    [No Abstract]   [Full Text] [Related]  

  • 36. Purification and properties of anti-Trypanosoma cruzi antibodies isolated from patients with chronic Chagas' disease.
    Hajos SE; Carbonetto C; Margni RA; Esteva M; Segura EL
    Immunol Lett; 1982 Apr; 4(4):199-203. PubMed ID: 6807842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flagellar antigens and the leucocyte migration-inhibition test in Chagas patients.
    Patrucco A; Cerisola JA; Michel M; Chiale P; Alvarez M; Segura EL
    Trans R Soc Trop Med Hyg; 1978; 72(4):425-6. PubMed ID: 100910
    [No Abstract]   [Full Text] [Related]  

  • 38. Trypanosoma cruzi: protective immunization of susceptible strains of mice prone to autoimmunity.
    Nickell SP; Boyer MH
    Exp Parasitol; 1986 Dec; 62(3):450-2. PubMed ID: 3096772
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of BCG on the course of experimental Chagas' disease in mice.
    Kuhn RE; Vaughn RT; Herbst GA
    Int J Parasitol; 1975 Oct; 5(5):557-60. PubMed ID: 808508
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of sex of mice in relation to their response to immunization with vaccines prepared from Trypanosoma cruzi.
    McHardy N
    Trans R Soc Trop Med Hyg; 1978; 72(2):201-2. PubMed ID: 418539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.